Artemis Medicare Services Ltd (NSE:ARTEMISMED), a leading healthcare provider operating 800+ beds, anchored by a quaternary care, super-specialty hospital, reported a rise in third-quarter and nine-month earnings on the back of higher patient volumes, improved pricing and a sharp increase in overseas patient revenue. The company focuses on high-acuity treatments, medical value travel and selective capacity expansion across India.
Key Financial Updates – Q3 & 9M 2025
- For the quarter ended December 31, 2025, the company’s consolidated revenue from operations rose 17.2% year-on-year to ₹27,235 lakh.
- Net profit increased 7.9% to ₹2,223 lakh, Artemis said in a statement. Earnings before interest, tax, depreciation and amortization (EBITDA) grew 12.5% to ₹5,203 lakh.
- The company attributed the performance to a favorable case and payer mix, higher international patient inflows and continued operational efficiencies.
- Revenue from overseas patients surged 34.9% to ₹8,750 lakh during the quarter and accounted for 34% of net revenue, underscoring the hospital’s growing exposure to medical value travel.
- For the first nine months of FY26, consolidated revenue from operations rose 15.1% to ₹80,202 lakh, while net profit jumped 23.9% to ₹7,343 lakh. EBITDA increased to ₹15,862 lakh from ₹13,654 lakh in the same period last year.
Hospital-level Performance
- At its flagship Artemis Hospital in Gurugram, revenue from operations climbed 20.2% year-on-year to ₹26,092 lakh in the December quarter.
- EBITDA stood at ₹5,200 lakh compared with ₹4,642 lakh a year earlier, while profit after tax (PAT) rose marginally to ₹2,499 lakh.
- Average revenue per occupied bed (ARPOB) increased to ₹84,100 from ₹76,485, reflecting higher acuity procedures and improved pricing.
- Bed occupancy remained stable at 62.0%, while the average length of stay declined slightly to 3.6 days from 3.7 days.
- Revenue from overseas patients surged 34.9% to ₹8,750 lakh during the quarter and accounted for 34% of net revenue, underscoring the hospital’s growing exposure to medical value travel.
Other Key Metrics
- For the first nine months of FY26, consolidated revenue from operations rose 15.1% to ₹80,202 lakh, while net profit jumped 23.9% to ₹7,343 lakh.
- EBITDA increased to ₹15,862 lakh from ₹13,654 lakh in the same period last year.
- At the Gurugram hospital level, revenue grew 17.5% to ₹76,277 lakh, EBITDA rose to ₹15,981 lakh, and PAT increased 13.6% to ₹8,200 lakh.
- ARPOB improved to ₹81,711, while bed utilization averaged 62.4% during the nine-month period.
- Overseas patient revenue for the nine months rose 32.2% to ₹24,042 lakh and contributed about 32% to net revenue, the company said.
Management Commentary
Chairman Onkar Kanwar said the company’s performance reflected sustained momentum in FY26, supported by disciplined execution, cost management and a focus on clinical quality. Further, profitability remained resilient due to strong international patient inflows and efficiency initiatives.
Outlook
Artemis said development of its Raipur hospital facility is progressing as planned, with operations expected to commence in April 2026, as the company continues to pursue network expansion and long-term growth opportunities.